| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |